Sinopharm Group Co. Ltd. (SHTDY) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Sinopharm Group Co. Ltd.

OTC: SHTDY · Real-Time Price · USD
11.97
0.00 (0.03%)
At close: Oct 03, 2025, 3:58 PM
11.97
-0.03%
After-hours: Oct 01, 2025, 08:00 PM EDT

Sinopharm Balance Sheet Statement

Financials in CNY. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
54.31B 63.81B 55.22B 43.53B
Short-Term Investments
158K 547K 498K 11.75M
Long-Term Investments
10.89B 10.55B 9.84B 9.17B
Other Long-Term Assets
1.48B 6.1B 3.73B 3.73B
Receivables
206.72B 185.79B 171.2B 172.58B
Inventory
62.35B 60.03B 60.93B 51.5B
Other Current Assets
14.05B 16.18B 16.57B 13.39B
Total Current Assets
347.45B 336.84B 319.41B 290.92B
Property-Plant & Equipment
19.63B 19.9B 17.79B 17.6B
Goodwill & Intangibles
10.97B 10.02B 12.03B 12.2B
Total Long-Term Assets
45.38B 46.56B 45.37B 44.49B
Total Assets
392.83B 383.39B 364.78B 335.41B
Account Payables
156.87B 154.75B 144.62B 132.87B
Deferred Revenue
n/a n/a n/a 21.62B
Short-Term Debt
62.73B 54.73B 53B 55.15B
Other Current Liabilities
16.57B 17.52B 21.95B -3.89B
Total Current Liabilities
250.38B 241.49B 234.96B 219.31B
Long-Term Debt
8.64B 13.83B 11.75B 8.42B
Other Long-Term Liabilities
3.87B 3.09B 3.36B 3.3B
Total Long-Term Liabilities
15.77B 21.59B 19.74B 16.45B
Total Liabilities
266.14B 263.08B 254.71B 235.76B
Total Debt
76.39B 73.78B 69.59B 68.37B
Book Value
126.69B 120.32B 110.07B 99.65B
Book Value Per Share
202.99 192.78 176.36 160.16
Common Stock
3.12B 3.12B 3.12B 3.12B
Retained Earnings
53.74B 49.41B 42.87B 38.52B
Comprehensive Income
22.02B -4.37B -4.39B -4.39B
Shareholders Equity
78.88B 74.58B 68.07B 61.89B
Total Investments
10.89B 10.55B 9.84B 9.18B